- Lung cancer is the
second most common form of cancer worldwide. - Each year, around 2 million people receive a lung cancer diagnosis, and 1.8 million people die of the disease.
- There are two types of lung cancer — small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) — with NSCLC causing the majority of cases.
- NSCLC can be treated with surgery, radiation, and chemotherapy, but is rarely cured.
- Now, research has found that, in mice with NSCLC, a combination of two drugs reduces tumor size and number, a finding that may lead to clinical trials in people.
According to the
It is also the leading cause of cancer deaths, accounting for one in five deaths from cancer‚ more than colon, breast, and prostate cancers combined.
Most lung cancer cases are diagnosed in older people, with the average age of diagnosis being 70 years. The good news is that cases are falling as fewer people are smoking tobacco, which causes
However, some
Now, a team from the Salk Institute and Northwestern University has found that a combination of two drugs, one already licensed by the Food and Drug Administration (FDA), and the other currently in clinical trials, reduced tumor size and number in mice with NSCLC.
The research is published in Science Advances.
“This treatment would be effective for patients with
“Each year in the U.S., there are [about] 20,000 new cases of this molecular subtype…
Read the full article here